Clinical Research Directory
Browse clinical research sites, groups, and studies.
MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK
Sponsor: Insel Gruppe AG, University Hospital Bern
Summary
Sepsis-induced immunosuppression (SIS) is a common complication in patients with septic shock. Reduced expression of Human leukocyte antigen isotype DR (HLA-DR) on circulating monocytes is a marker for SIS and correlates with risk of secondary infections and mortality. The miRSep study aims to improve the understanding of early microRNA (miRNA) mediated changes in HLA-DR on monocytes in patients with septic shock.
Official title: MIRSEP - MIRNA QUANTIFICATION IN PATIENTS WITH SEPTIC SHOCK
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
56
Start Date
2026-06-01
Completion Date
2027-12-31
Last Updated
2026-05-22
Healthy Volunteers
No
Conditions
Locations (1)
Inselspital
Bern, Switzerland